DONADINI, MARCO PAOLO
DONADINI, MARCO PAOLO
DIPARTIMENTO DI MEDICINA E CHIRURGIA
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm
2018-01-01 Riva, N.; Camporese, G.; Iotti, M.; Bucherini, E.; Righini, M.; Kamphuisen, P. W.; Verhamme, P.; Douketis, J. D.; Tonello, C.; Prandoni, P.; Ageno, W.; Ghirarduzzi, A.; Veropalumbo, M. R.; Donadini, M.
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis
2008-01-01 Donadini, MARCO PAOLO; Dentali, Francesco; Squizzato, Alessandro; Ageno, Walter
Anticoagulant treatment for Upper Extremity Deep Vein thrombosis: a systematic review and meta-analysis
2021-01-01 Valeriani, Emanuele; Di Nisio, Marcello; Porceddu, Enrica; Agostini, Fabiana; Pola, Roberto; Spoto, Silvia; Donadini, Marco Paolo; Ageno, Walter; Porfidia, Angelo
Antidotes for the direct oral anticoagulants: What news?
2018-01-01 Galliazzo, S.; Donadini, M. P.; Ageno, W.
Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations
2010-01-01 Donadini, M; Crowther, Mark
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis
2023-01-01 Valeriani, Emanuele; Paciullo, Francesco; Porfidia, Angelo; Pignatelli, Pasquale; Candeloro, Matteo; Di Nisio, Marcello; Donadini, Marco Paolo; Mastroianni, Claudio Maria; Pola, Roberto; Gresele, Paolo; Ageno, Walter
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET)
2022-01-01 Paciullo, Francesco; Valeriani, Emanuele; Porfidia, Angelo; Di Nisio, Marcello; Donadini, MARCO PAOLO; Marcucci, Rossella; Prisco, Domenico; Cagini, Carlo; Gresele, Paolo; Ageno, Walter
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events
2018-01-01 Donadini, Marco P.; Bellesini, Marta; Squizzato, Alessandro
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis
2012-01-01 Warkentin, A. E.; Donadini, M; Spencer, F. A.; Lim, W.; Crowther, M.
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.
2009-01-01 Donadini, MARCO PAOLO; Dentali, Francesco; Ageno, Walter
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.
2009-01-01 Dentali, Francesco; Donadini, M; Gianni, M; Bertolini, A; Lonn, E; Venco, A; Cattozzo, G; Ageno, Walter
Brand name versus generic warfarin: a systematic review of the literature.
2011-01-01 Dentali, Francesco; Donadini, MARCO PAOLO; Nathan, Clark; Mark, Crowther; David, Garcia; Elaine, Hylek; Daniel, Witt; Ageno, Walter
Breadth of complications of long-term oral anticoagulant care
2018-01-01 Ageno, Walter; Donadini, Marco
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies
2013-01-01 Donadini, M. P.; Ageno, Walter; Guasti, Luigina; Squizzato, Alessandro
Clinical approach to splanchnic vein thrombosis: Risk factors and treatment.
2012-01-01 Riva, N; Donadini, Mp; Dentali, Francesco; Squizzato, Alessandro; Ageno, Walter
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events
2017-01-01 Squizzato, Alessandro; Bellesini, Marta; Takeda, Andrea; Middeldorp, Saskia; Donadini, Marco Paolo
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?
2010-01-01 Donadini, M; Douketis James, D.
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients
2022-01-01 Santagata, D.; Camma, G.; Donadini, M. P.; Squizzato, A.; Ageno, W.
Development of personalized thrombogenesis and thrombin generation assays to assess endothelial dysfunction in cardiovascular diseases
2023-01-01 Bacci, M.; Cancellara, A.; Ciceri, R.; Romualdi, E.; Pessi, V.; Tumminello, F.; Fantuzzi, M.; Donadini, M. P.; Lodigiani, C.; Della Bella, S.; Calcaterra, F.; Mavilio, D.
DOACs use in extreme body-weighted patients: results from the prospective START-register
2023-01-01 Guarascio, M.; Bertù, L.; Donadini, M. P.; Antonucci, E.; Palareti, G.; Ageno, W.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm | 1-gen-2018 | Riva, N.; Camporese, G.; Iotti, M.; Bucherini, E.; Righini, M.; Kamphuisen, P. W.; Verhamme, P.; Douketis, J. D.; Tonello, C.; Prandoni, P.; Ageno, W.; Ghirarduzzi, A.; Veropalumbo, M. R.; Donadini, M. | |
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis | 1-gen-2008 | Donadini, MARCO PAOLO; Dentali, Francesco; Squizzato, Alessandro; Ageno, Walter | |
Anticoagulant treatment for Upper Extremity Deep Vein thrombosis: a systematic review and meta-analysis | 1-gen-2021 | Valeriani, Emanuele; Di Nisio, Marcello; Porceddu, Enrica; Agostini, Fabiana; Pola, Roberto; Spoto, Silvia; Donadini, Marco Paolo; Ageno, Walter; Porfidia, Angelo | |
Antidotes for the direct oral anticoagulants: What news? | 1-gen-2018 | Galliazzo, S.; Donadini, M. P.; Ageno, W. | |
Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations | 1-gen-2010 | Donadini, M; Crowther, Mark | |
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis | 1-gen-2023 | Valeriani, Emanuele; Paciullo, Francesco; Porfidia, Angelo; Pignatelli, Pasquale; Candeloro, Matteo; Di Nisio, Marcello; Donadini, Marco Paolo; Mastroianni, Claudio Maria; Pola, Roberto; Gresele, Paolo; Ageno, Walter | |
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET) | 1-gen-2022 | Paciullo, Francesco; Valeriani, Emanuele; Porfidia, Angelo; Di Nisio, Marcello; Donadini, MARCO PAOLO; Marcucci, Rossella; Prisco, Domenico; Cagini, Carlo; Gresele, Paolo; Ageno, Walter | |
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events | 1-gen-2018 | Donadini, Marco P.; Bellesini, Marta; Squizzato, Alessandro | |
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis | 1-gen-2012 | Warkentin, A. E.; Donadini, M; Spencer, F. A.; Lim, W.; Crowther, M. | |
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension. | 1-gen-2009 | Donadini, MARCO PAOLO; Dentali, Francesco; Ageno, Walter | |
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism. | 1-gen-2009 | Dentali, Francesco; Donadini, M; Gianni, M; Bertolini, A; Lonn, E; Venco, A; Cattozzo, G; Ageno, Walter | |
Brand name versus generic warfarin: a systematic review of the literature. | 1-gen-2011 | Dentali, Francesco; Donadini, MARCO PAOLO; Nathan, Clark; Mark, Crowther; David, Garcia; Elaine, Hylek; Daniel, Witt; Ageno, Walter | |
Breadth of complications of long-term oral anticoagulant care | 1-gen-2018 | Ageno, Walter; Donadini, Marco | |
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies | 1-gen-2013 | Donadini, M. P.; Ageno, Walter; Guasti, Luigina; Squizzato, Alessandro | |
Clinical approach to splanchnic vein thrombosis: Risk factors and treatment. | 1-gen-2012 | Riva, N; Donadini, Mp; Dentali, Francesco; Squizzato, Alessandro; Ageno, Walter | |
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events | 1-gen-2017 | Squizzato, Alessandro; Bellesini, Marta; Takeda, Andrea; Middeldorp, Saskia; Donadini, Marco Paolo | |
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it? | 1-gen-2010 | Donadini, M; Douketis James, D. | |
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients | 1-gen-2022 | Santagata, D.; Camma, G.; Donadini, M. P.; Squizzato, A.; Ageno, W. | |
Development of personalized thrombogenesis and thrombin generation assays to assess endothelial dysfunction in cardiovascular diseases | 1-gen-2023 | Bacci, M.; Cancellara, A.; Ciceri, R.; Romualdi, E.; Pessi, V.; Tumminello, F.; Fantuzzi, M.; Donadini, M. P.; Lodigiani, C.; Della Bella, S.; Calcaterra, F.; Mavilio, D. | |
DOACs use in extreme body-weighted patients: results from the prospective START-register | 1-gen-2023 | Guarascio, M.; Bertù, L.; Donadini, M. P.; Antonucci, E.; Palareti, G.; Ageno, W. |